title: Development and Validation of a Universal High-Throughput UDP-Glycosyltransferase Assay with a Time-Resolved FRET Signal.
abstract: Glycosyltransferase enzymes play diverse metabolic and regulatory roles by catalyzing the transfer of sugar molecules to protein, lipid, and carbohydrate acceptors, and they are increasingly of interest as therapeutic targets in a number of diseases, including metabolic disorders, cancer, and infectious diseases. The glycosyltransferases are a challenging target class from an assay development perspective because of the diversity of both donor and acceptor substrates and the lack of suitable glycan detection methods. However, many glycosyltransferases use uridine 5'-diphosphate (UDP) sugars as donor substrates, and detection of the free UDP reaction product provides a generic approach for measuring the activity of those enzymes. To exploit this approach for a broadly applicable high-throughput screening (HTS) assay for discovery of glycosyltransferase inhibitors, we developed a Transcreener(®) assay for immunodetection of UDP with a time-resolved Förster resonance energy transfer (TR-FRET) signal. We optimized the assay for detection of glycosyltransferase activity with nucleotide diphosphate (NDP) sugars at concentrations from 10 μM to 1 mM, achieving Z' values of 0.6 or higher. The assay was validated by orthogonal pooled screening with 8,000 compounds using polypeptide N-acetylgalactosaminyltransferase T3 as the target, and the hits were confirmed using an orthogonal readout. The reagents and signal were both stable for more than 8 h at room temperature, insuring robust performance in automated HTS environments. The TR-FRET-based UDP detection assay provides a broadly applicable approach for screening glycosyltransferases that use a UDP-sugar donor.
authors.affiliation: 1 BellBrook Labs , Madison, Wisconsin.
authors.forename: Thomas
authors.initials: T
authors.lastname: Zielinski
authors.affiliation: 2 Lankenau Institute for Medical Research , Wynnewood, Pennsylvania.
authors.forename: Melvin
authors.initials: M
authors.lastname: Reichman
authors.affiliation: 2 Lankenau Institute for Medical Research , Wynnewood, Pennsylvania.
authors.forename: Preston S
authors.initials: PS
authors.lastname: Donover
authors.affiliation: 1 BellBrook Labs , Madison, Wisconsin.
authors.forename: Robert G
authors.initials: RG
authors.lastname: Lowery
mesh_terms: D001667:Binding, Competitive / Q000502:physiology; D031541:Fluorescence Resonance Energy Transfer / Q000379:methods / Q000592:standards*; D015200:Fluoroimmunoassay / Q000379:methods / Q000592:standards; D057166:High-Throughput Screening Assays / Q000379:methods / Q000592:standards*; D006801:Humans; D017350:N-Acetylgalactosaminyltransferases / Q000032:analysis* / Q000378:metabolism*; D010865:Pilot Projects; D000097763:Polypeptide N-acetylgalactosaminyltransferase
chemical_list: D017350:N-Acetylgalactosaminyltransferases; D000097763:Polypeptide N-acetylgalactosaminyltransferase